Loading...
XSHE
000590
Market cap280mUSD
Jul 10, Last price  
8.19CNY
1D
3.02%
1Q
-28.03%
Jan 2017
-58.32%
Name

Tus Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000590 chart
P/E
P/S
5.81
EPS
Div Yield, %
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
2.34%
Revenues
338m
-1.61%
236,573,558274,089,961311,624,913343,508,517363,420,444256,000,678203,121,999294,719,554301,464,441292,867,253185,811,015315,034,457275,090,121300,774,612300,774,612350,528,110350,528,109404,647,907343,208,128337,673,206
Net income
-51m
L-59.74%
20,374,461047,153,71372,134,381137,606,337-164,450,530-85,770,53822,372,28355,175,21819,173,760-38,180,40242,442,31222,722,39935,438,60335,438,60918,109,85418,109,85525,246,780-125,471,520-50,516,758
CFO
29m
+66.54%
068,039,94934,885,63234,144,67784,978,22630,866,20619,746,0604,122,1590000654,23729,208,43651,480,57925,196,29654,473,687-28,394,71717,387,97228,957,222
Dividend
Jun 21, 20130.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries, operates as a prominent Chinese pharmaceutical enterprise. The company focuses on the production and distribution of traditional Chinese medicine (TCM), conventional chemical pharmaceuticals, and health supplements within the domestic market. Its business activities are organized into specific segments, including the manufacturing and sale of traditional Chinese medicine, the manufacturing and sale of Western medicine, and a range of other operations. The company boasts a comprehensive product catalog featuring both prescription and over-the-counter (OTC) drugs. This selection includes tonics and health-boosting preparations, medications for cardiovascular and cerebrovascular conditions, nutritional products for children, cold and flu remedies, and detoxifying agents. Beyond its core manufacturing, Guhan Pharmaceutical is involved in a diverse array of additional services and ventures. These encompass health and nutrition advisory services, the cultivation of Chinese medicinal herbs, extensive medical research and experimental development, planning for cultural and artistic exchanges, general medical consultations, online sales, technology promotion, consulting agent services, outpatient care, and comprehensive pharmaceutical wholesale and retail operations. Founded in 1956, the company is headquartered in Hengyang, China. It was previously known as Tus-Pharmaceutical Group Co., Ltd., officially adopting its current name, Guhan Pharmaceutical Group Co., Ltd., in November 2025.
IPO date
Jan 19, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT